Market
Synopsis of Global Retropharyngeal Abscess Market:
Market
scenario:
A
retropharyngeal abscess is a serious infection, usually starts in the lymph
nodes, characterised by collection of pus at the back of the throat.
Retropharyngeal abscess typically occurs in children under the age of eight,
sometimes it can also affect adults. The symptoms of retropharyngeal abscess
include difficulty or noisy breathing, difficulty and pain while swallowing,
drooling, severe cough, severe throat pain, neck stiffness or swelling, muscle
spasms in the neck among others. Retropharyngeal abscess is generally preceded
by upper respiratory infections mostly a middle ear or sinus infection.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4922
The causes of retropharyngeal
abscess are trauma or injury, medical procedure, dental procedures, alcohol
intake, diabetes, cancer, AIDS, weakened immune system or a chronic diseases
such as tuberculosis and others. Other complications indicated are pneumonia,
blood clots in the jugular vein, mediastinitis, osteomyelitis and others. If
left untreated, retropharyngeal abscess infection can spread to other parts of
the body resulting in septic shock and organ failure. In severe instances, a
retropharyngeal abscess can lead to death. The most common bacteria involved
are Streptococcus, Staphylococcus, and others. Other infections, such as HIV
and tuberculosis can also cause the retropharyngeal abscess. Retropharyngeal
abscess recurs in an estimated 1 to 5% of patients and such patients are 40 to
50% more likely to die due to abscess-related complications. Retropharyngeal
abscess also slightly more common in males than females.
The market drivers for global
retropharyngeal abscess market, are rise in demand due to the growing younger
and susceptible population, increasing screening, urgency of the
retropharyngeal abscess treatment, and rise in risk factors. The rise in cases
of retropharyngeal abscess due to increase in Methicillin-resistant
Staphylococcus aureus (MRSA) infections also stimulates the market. The market
restraints are complications such as risk of bleeding, infections, pain,
especially during surgery, high cost of retropharyngeal abscess treatment, lack
of cardiac care infrastructure, and lack of focus on other diseases by the
developing regions and others.
The global retropharyngeal
abscess market is expected to reach USD 5.9 billion by 2023, and the market is
projected to grow at a CAGR of ~ 4.5 % during the forecast period 2017-2023.
Segments
The global retropharyngeal abscess market has been segmented on the basis of diagnosis, treatment, and end user.
The global retropharyngeal abscess market has been segmented on the basis of diagnosis, treatment, and end user.
Based on the diagnosis, the
market has been segmented as X-rays and computed tomography, blood tests,
physical exam and others.
Based on the treatment, the
market has been segmented as calcium antibiotics, pain killers, surgical
drainage and others.
Based on the end user, the market
has been segmented as hospitals and clinics, research and academics and others.
Regional Analysis
A significant market share of the global retropharyngeal abscess market is held by the Americas, owing to high expenditure on the health care especially in major countries of the region like the U.S. and Canada. Additionally, the number of cardiac procedures in the U.S and Canada is increasing due to greater healthcare penetration, which drives the retropharyngeal abscess market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of infective procedures treatment in the returns of hospitals favors the market. The large number of pharmaceutical companies in the U.S. is also a cause for the faster development of retropharyngeal abscess market in the US. The development of broad spectrum antibiotics in developed regions such as the U.S. and Europe is a strong driver of the market.
A significant market share of the global retropharyngeal abscess market is held by the Americas, owing to high expenditure on the health care especially in major countries of the region like the U.S. and Canada. Additionally, the number of cardiac procedures in the U.S and Canada is increasing due to greater healthcare penetration, which drives the retropharyngeal abscess market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of infective procedures treatment in the returns of hospitals favors the market. The large number of pharmaceutical companies in the U.S. is also a cause for the faster development of retropharyngeal abscess market in the US. The development of broad spectrum antibiotics in developed regions such as the U.S. and Europe is a strong driver of the market.
Europe is the second largest
market in the world due to growing pharmaceutical industry and healthcare
penetration. The European market growth is led by countries such as Germany and
France. Germany is expected to be the fastest growing market over the
assessment period due to its large pharmaceutical and microsurgery devices
industry. The development of Methicillin-resistant Staphylococcus aureus (MRSA)
especially in the southern regions of Europe such as Spain, Italy etc.
stimulates the market.
Asia Pacific region is expected
to grow rapidly; China and India are likely to lead this market due to fast
growing healthcare sector and large unmet needs over the forecast period. South
East Asian countries such as China, India, and Malaysia are projected to
contribute highly to the market growth. The growing penetration of healthcare
industry in the Asia Pacific region is expected to drive the future
retropharyngeal abscess market in the region. However the low expenditure on
healthcare coupled with the poor incomes in the developing regions is a dent on
the market.
Gulf nations such as Saudi Arabia
and the UAE are estimated to drive the Middle East & African market. Other
Middle East nations to watch out for are Kuwait, Jordan, Egypt and Iran. The
African region is expected to witness a poor growth owing to poor economic and
political conditions, and poor healthcare development. Other regions are
expected to be laggards due to poor social development and tribal identities
such as sub Saharan Africa.
Key Players in the Global
Retropharyngeal abscess Market
Some of the key players profiled in the report are Merck KGaA, Johnson & Johnson, AstraZeneca plc, Sanofi S.A., Pfizer, Mylan N.V, Novartis AG, Teva pharmaceutical company, GlaxoSmithKline plc., and others.
Some of the key players profiled in the report are Merck KGaA, Johnson & Johnson, AstraZeneca plc, Sanofi S.A., Pfizer, Mylan N.V, Novartis AG, Teva pharmaceutical company, GlaxoSmithKline plc., and others.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4922
Detailed Table
of Contents:
Table Of Contents
1. Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2. Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4. Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
...Continued
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email:
sales@marketresearchfuture.com